AZN.UK

10,328

+1.65%↑

GSK

1,398

+2.61%↑

INDV

835

+1.46%↑

AZN.UK

10,328

+1.65%↑

GSK

1,398

+2.61%↑

INDV

835

+1.46%↑

AZN.UK

10,328

+1.65%↑

GSK

1,398

+2.61%↑

INDV

835

+1.46%↑

AZN.UK

10,328

+1.65%↑

GSK

1,398

+2.61%↑

INDV

835

+1.46%↑

AZN.UK

10,328

+1.65%↑

GSK

1,398

+2.61%↑

INDV

835

+1.46%↑

Search

Oxford Biomedica PLC

Fermé

293.5 1.03

Résumé

Variation du prix de l'action

24h

Actuel

Min

293.5

Max

299.5

Chiffres clés

By Trading Economics

Revenu

22M

-11M

Ventes

27M

78M

Marge bénéficiaire

-13.726

Employés

850

EBITDA

25M

5M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+115.17% upside

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

4.8M

313M

Ouverture précédente

292.47

Clôture précédente

293.5

Oxford Biomedica PLC Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

16 mai 2025, 19:39 UTC

Principaux Mouvements du Marché

UroGen Falls to 52-Week Low, FDA Document Indicates Cancer Drug Study Disagreement

17 mai 2025, 09:30 UTC

Actualités
Résultats

In a Trade War, Walmart Lacks Some of Amazon's Ammunition -- Heard on the Street -- WSJ

17 mai 2025, 08:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 mai 2025, 08:20 UTC

Market Talk
Résultats

Financial Services Roundup: Market Talk

17 mai 2025, 05:30 UTC

Acquisitions, Fusions, Rachats

Tradeweb Is Looking to Come to a Bond Market Near You -- Barrons.com

16 mai 2025, 23:18 UTC

Actualités

U.S. Loses Last Triple-A Credit Rating -- 2nd Update

16 mai 2025, 22:30 UTC

Actualités

U.S. Loses Last Triple-A Credit Rating -- Update

16 mai 2025, 21:56 UTC

Market Talk

Fitch Raises Greece's Outlook to Positive From Stable -- Market Talk

16 mai 2025, 21:56 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16 mai 2025, 21:54 UTC

Actualités

U.S. Loses Last Triple-A Credit Rating -- WSJ

16 mai 2025, 21:22 UTC

Market Talk

Moody's Says U.S. Fiscal Performance Likely to Deteriorate -- Market Talk

16 mai 2025, 21:17 UTC

Market Talk

Treasury Yields Rise, Dollar Falls After Moody's Cuts U.S. Credit Rating -- Market Talk

16 mai 2025, 21:17 UTC

Actualités

The Score: UnitedHealth, Walmart, Coinbase Global and More Stocks That Moved on the Week's News -- WSJ

16 mai 2025, 21:05 UTC

Market Talk

Moody's Downgrades U.S. Credit Rating Due to Deficit, Debts -- Market Talk

16 mai 2025, 20:55 UTC

Acquisitions, Fusions, Rachats

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

16 mai 2025, 20:50 UTC

Market Talk
Résultats

Financial Services Roundup: Market Talk

16 mai 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

16 mai 2025, 20:37 UTC

Actualités

Trade Progress Sparks Bullish Week for Wall Street -- WSJ

16 mai 2025, 20:33 UTC

Market Talk
Acquisitions, Fusions, Rachats

Dick's-Foot Locker Deal Looks Like a Bet on Nike's Turnaround -- Market Talk

16 mai 2025, 20:30 UTC

Acquisitions, Fusions, Rachats

Galaxy Digital Begins U.S. Trading as Bitcoin Keeps Powering Ahead -- Barrons.com

16 mai 2025, 20:18 UTC

Actualités

Major U.S. Stock Indexes Rise; U.S. Running Out of Patience for Trade Deals -- WSJ

16 mai 2025, 20:16 UTC

Actualités

Justice Department Wants to Spare Boeing From Guilty Plea Over 737 MAX Charges -- 3rd Update

16 mai 2025, 20:15 UTC

Résultats

Tesla Stock Rises. Even Hedge Fund Sales Can't Keep It Down. -- Barrons.com

16 mai 2025, 20:11 UTC

Acquisitions, Fusions, Rachats

Henry Schein: William K. Daniel Joins Board

16 mai 2025, 20:10 UTC

Acquisitions, Fusions, Rachats

Henry Schein: Strategic Investment by KKR Completed

16 mai 2025, 20:05 UTC

Acquisitions, Fusions, Rachats

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

16 mai 2025, 19:38 UTC

Market Talk

Oil Futures Post Second Straight Weekly Gain -- Market Talk

16 mai 2025, 19:07 UTC

Market Talk

U.S. Natural Gas Futures End Week Lower -- Market Talk

16 mai 2025, 18:51 UTC

Actualités

Early Read on Consumer Sentiment Falls to Second Lowest on Record -- 5th Update

16 mai 2025, 18:41 UTC

Acquisitions, Fusions, Rachats

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

Comparaison

Variation de prix

Oxford Biomedica PLC prévision

Objectif de Prix

By TipRanks

115.17% hausse

Prévisions sur 12 Mois

Moyen 649.825 GBX  115.17%

Haut 800 GBX

Bas 500 GBX

Basé sur 2 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

2 ratings

2

Achat

0

Maintien

0

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Oxford Biomedica PLC

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, adenoviral vectors, and other viral vector types. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.